Merck recently announced that it will pay $688 million to settle two class action lawsuits brought by pension funds and other shareholders. The investors accused the company of withholding n... Read more
Merck & Co. has settled a patent dispute with Glenmark Pharmaceuticals involving the cholesterol drug Zetia, one of its best-selling products. The lawsuit had been scheduled to go to tri... Read more
U.S. drug regulators are investigating whether the cholesterol-lowering drug Vytorin might be linked to cancer. The U.S. Food and Drug Administration informed health-care professionals that... Read more
Information revealed last month to a Congressional committee relating to drug trials is very disturbing. The lead outside investigator on a crucial trial of two widely used heart drugs said... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.